Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-11-11

Clinical Trial Update: A Study of OLR in First-line Treatment of Mantle Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for OLR as first-line treatment in mantle cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • OLR

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Mantle Cell Lymphoma | Phase 2 | Status: UNKNOWN